Back

Life expectancy and early to mid-term dysfunction of transcatheter aortic prostheses: incidence, modes, correlates, and outcome.

27 August 2022 (14:15 - 15:00)
Organised by:
Congress Presentation Part of: Aortic valve intervention 3 Aortic Valve Intervention ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Christian Nitsche

Medical University of Vienna, Vienna (Austria)

6 More presentations in this session

Presentation thumbnail
Transcatheter aortic valve implantation without contrast media technique in chronic kidney disease population - pilot study
Mr F. Barcellos Filippini (Sao Paulo, BR)
Abstract Slides
Presentation thumbnail
Transcatheter aortic valve implantation (TAVI) with zero contrast in patients with impairment of renal function. A single centre experience
Doctor N. Travaglio (Rapallo, IT)
Abstract Slides
Presentation thumbnail
Transcatheter aortic valve implantation outcomes in patients with low flow low gradient aortic stenosis
Doctor A. Grazina (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Prognostic impact of left ventricular ejection fraction recovery in patients undergoing pecutaneous aortic valve replacement
Doctor D. Lopez Otero (Santiago de Compostela, ES)
Abstract Slides
Presentation thumbnail
Prognostic value of right ventricular dysfunction in patients undergoing transcatheter aortic valve replacement
Mr J. Jimeno Sanchez (Zaragoza, ES)
Abstract Slides

Access the full session

Session thumbnail
Aortic valve intervention 3

The Event

Event poster

ESC Congress 2022

27 August 2022 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Aortic regurgitation and stenosis: diagnosis and mode of intervention
thumbnail
Congress Session
Failing valves and beyond
thumbnail
Congress Session
Controversies in heart valve disease: integrating art, science, medicine, and surgery into decision-making

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources